🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Ginkgo Bioworks Holdings, Inc.

DNA Healthcare
$6.9 +$0.11 (1.62%)
Market Cap: $401.63 M
Gurus Holding
5
Popularity Rank
#1734
% of Shares Held
7.16%
Net Activity (Q4 2025)
+$2.42 M

Guru Ownership Trend

Guru Analysis for Ginkgo Bioworks Holdings, Inc. (DNA)

Ginkgo Bioworks Holdings, Inc. (DNA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $28.76 M.

Top institutional holders include Andreas Halvorsen and Paul Tudor Jones.

Institutional sentiment is currently Bullish. This is evidenced by a $2.42 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who opened a new position.

Key Holders

Top 5 by Value

$1.42 M
$1.24 M
$639,105

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$2.42 M
Total Buy Value
New Buys 2
Additions 1
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
0
Net Buyers
3

FAQs for Ginkgo Bioworks Holdings, Inc. (DNA)

Major holders include Andreas Halvorsen ($29.73 M), Paul Tudor Jones ($1.61 M), Cliff Asness ($1.42 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 4.17 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.42 M, with 3 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in DNA during the most recent reporting period.

Yes, 2 managers opened new positions in DNA, and 1 increased their existing holdings. The total reported buy value was $2.42 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.08% 3,577,128 $29.73 M Q4 2025
0.00% New Buy 193,962 $1.61 M Q4 2025
0.00% Add 13.2% 170,555 $1.42 M Q4 2025
0.03% 149,379 $1.24 M Q4 2025
0.00% New Buy 76,908 $639,105 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form